Instadose Pharma Corp Stock Analysis
| INSD Stock | USD 0 0.00 0.00% |
Instadose Pharma Corp is overvalued with Real Value of 9.24E-4 and Hype Value of 0.0011. The main objective of Instadose Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Instadose Pharma Corp is worth, separate from its market price. There are two main types of Instadose Pharma's stock analysis: fundamental analysis and technical analysis.
The Instadose Pharma stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Instadose Pharma's ongoing operational relationships across important fundamental and technical indicators.
Instadose |
Instadose Stock Analysis Notes
About 34.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Instadose Pharma Corp recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada. Instadose Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. To learn more about Instadose Pharma Corp call Antonio Franchino at 905 218 3593 or check out https://www.instadosepharma.com.Instadose Pharma Corp Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Instadose Pharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Instadose Pharma Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Instadose Pharma generated a negative expected return over the last 90 days | |
| Instadose Pharma has some characteristics of a very speculative penny stock | |
| Instadose Pharma Corp currently holds about 5.33 K in cash with (65) of positive cash flow from operations. | |
| Instadose Pharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 34.0% of the company shares are held by company insiders |
Instadose Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 585.13 K.Instadose Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (225.67) | (236.96) | |
| Return On Capital Employed | 2.60 | 2.73 | |
| Return On Assets | (225.67) | (236.96) | |
| Return On Equity | 2.56 | 2.69 |
Management Efficiency
Instadose Pharma Corp has return on total asset (ROA) of (694.0616) % which means that it has lost $694.0616 on every $100 spent on assets. This is way below average. Instadose Pharma's management efficiency ratios could be used to measure how well Instadose Pharma manages its routine affairs as well as how well it operates its assets and liabilities. At present, Instadose Pharma's Return On Equity is projected to increase slightly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about (138.8 K). The current year's Net Current Asset Value is expected to grow to about (225.8 K)| Last Reported | Projected for Next Year | ||
| Net Current Asset Value | -237.7 K | -225.8 K | |
| Tangible Asset Value | -237.7 K | -225.8 K | |
| Enterprise Value Over EBITDA | (367.79) | (386.18) | |
| Price Book Value Ratio | -10.3 K | -9.8 K | |
| Enterprise Value Multiple | (367.79) | (386.18) | |
| Price Fair Value | -10.3 K | -9.8 K | |
| Enterprise Value | 1.7 B | 1.7 B |
Leadership at Instadose Pharma emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Beta (945.30) | Return On Assets (694.06) |
Technical Drivers
Instadose Pharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Instadose Pharma Corp Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Instadose Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Instadose Pharma Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Instadose Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Instadose Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Instadose shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Instadose Pharma. By using and applying Instadose Stock analysis, traders can create a robust methodology for identifying Instadose entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (7.80) | (8.19) | |
| Operating Profit Margin | (5.88) | (6.17) | |
| Net Loss | (7.80) | (8.19) | |
| Gross Profit Margin | 0.44 | 0.39 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Instadose Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Complementary Tools for Instadose Stock analysis
When running Instadose Pharma's price analysis, check to measure Instadose Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Instadose Pharma is operating at the current time. Most of Instadose Pharma's value examination focuses on studying past and present price action to predict the probability of Instadose Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Instadose Pharma's price. Additionally, you may evaluate how the addition of Instadose Pharma to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |